Access cutting-edge breast neoplasms treatment through this clinical trial at a research site in Fredericksburg. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Fredericksburg location
Preparing your pre-screening questions…
Access breast neoplasms specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast neoplasms treatment provided free
Check if you qualify for this breast neoplasms clinical trial in Fredericksburg, VA
No-Cost Study Care
Local to Fredericksburg
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
For women diagnosed with early stage breast cancer, lumpectomy followed by radiation is a common treatment option. Radiation treatment is typically delivered to the whole breast, five times per week, for anywhere from 3 to 8 weeks. The radiation helps kill any cancer cells that may have been left over following the surgery but causes skin burns. Many studies have demonstrated that radiation to the whole breast is not necessary, that it can be delivered to a portion of the breast where the cancer is more likely to recur. A technique called a Permanent Breast Seed Implant (PBSI) involving the implantation of radioactive seeds has been developed to deliver the radiation to a portion of the breast. The procedure is performed on an out-patient basis under local anesthesia and light sedation. Because the radioactive seeds are permanently implanted in the breast, the patient is able to live a normal life while the seeds deliver the prescribed radiation to the breast. Previous studies on PBSI demonstrate that it is a safe and effective alternative form of radiation for appropriately selected patients after lumpectomy. However, those results have been obtained mainly from a single institution, with only 4 patients treated in another center. Further research is still needed to evaluate its safety in a multi-center setting. The purpose of this study is to ensure the appropriate training of clinicians who will be performing this procedure and to capture long term outcomes and rare complications if any.
Sponsor: Concure Oncology-Breast Microseed Inc.
Yes, this clinical trial (NCT02701244) has an active research site in Fredericksburg, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for breast neoplasms treatment options in Fredericksburg, VA, this clinical trial (NCT02701244) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fredericksburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all breast neoplasms clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Fredericksburg — not just this study.
Browse Breast Cancer Trials in Fredericksburg →